CK an effective approach for hyperopia, presbyopia
August 15th 2002Philadelphia-Conductive keratoplasty (CK), a collagen shrinking procedure, has produced good visual results for patients treated for hyperopia and presbyopia, according to researchers at the annual meeting of the American Society of Cataract and Refractive Surgery.
Capillary blood speed helps in NAION, ON diagnoses
August 1st 2002Fort Lauderdale, FL-Differences in local capillary blood speed characteristics in patients who have unilateral nonarteritic anterior ischemic optic neuropathy (NAION) and optic neuritis (ON) may help in the differential diagnosis of these two most common nonglaucomatous optic neuropathies, said Nathalie Collignon, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Sutureless lamellar keratoplasty now possible with two-component system
August 1st 2002Philadelphia-Fibrin glue, approved by the FDA to seal blood vessels, can be used for lamellar keratoplasty to keep the donor cornea in place until it is completely healed 2 to 3 weeks postoperatively, according to Herbert E. Kaufman, MD, who spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting here.
Wavefront-guided LASIK effective for higher-order aberrations
August 1st 2002Philadelphia-Improved visual outcomes were seen with wavefront-guided laser ablations because both lower- and higher-order aberrations were reduced. The residual higher-order aberrations were lower than those found in conventionally treated eyes, according to Stephen Brint, MD, who reported results from the CustomCornea study group here at the annual meeting of the American Society of Cataract and Refractive Surgery.
Excimer laser treatment now approved for irregular astigmatism
August 1st 2002Philadelphia-Excimer laser treatment using the Custom Cap (VISX, Sunnyvale, CA) method seems to be a promising therapeutic approach for reducing optical aberrations in eyes with less than satisfactory visual outcomes after refractive surgery.
Laser provides good myopic LASIK results in European trials
August 1st 2002Philadelphia-The Allegretto Wave excimer laser (WaveLight Laser Technologie AG, Erlangen, Germany) appears to be safe and effective when used for LASIK to correct myopia and myopic astigmatism. Ablations performed using this laser also seem to produce very little high-order aberration and coma after treatment, even when treatment is not guided by wavefront technology.
More options available for correction of high astigmatism
August 1st 2002Philadelphia-High astigmatism is often more difficult to manage because these patients may have various corneal problems, such as keratoconus, previous RK, or corneal grafts. Multiple strategies should be considered for providing maximal correction and protecting the corneal integrity, explained James P. Gills, MD, during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.
Phakic lens holds promise for correcting high myopia, hyperopia
August 1st 2002Philadelphia-Patients with high myopia and high hyperopia seemed to have a good response to the implantation of the Phakic Refractive Lens (PRL, Medennium Inc.), according to Kenneth J. Hoffer, MD, who reported on the phase III trial for myopia and the phase II trial for hyperopia during the American Society of Cataract and Refractive Surgery meeting here.
LASIK still popular procedure, but PRK, LASEK interest grows
August 1st 2002Philadelphia-LASIK is still a popular procedure although PRK and LASEK are gaining interest, according to the results of the 2nd annual world-wide refractive surgery survey conducted through the American Society of Cataract and Refractive Surgery (ASCRS) and the European Society of Cataract and Refractive Surgery.
AAO offers new patient education materials
August 1st 2002San Francisco-The American Academy of Ophthalmology (AAO) has available a new patient education eye fact sheet on ocular rosacea. This one-page handout explains the condition's causes and outlines treatment options. Eye fact sheets on this and other topics are available at www.aao.org.store.
Majority of patients satisfied with results of ICL
August 1st 2002Philadelphia-Most of the patients treated for high myopia with the Implantable Contact Lens (ICL, STAAR Surgical) were satisfied with their vision at the 2-year follow-up, said John A. Vukich, MD, who reported the interim results of the FDA clinical trial during the American Society of Cataract and Refractive Surgery annual meeting.
Microkeratome users benefit from control, safety, performance
August 1st 2002Philadelphia-The K-TOME microkeratome offers a range of desirable characteristics that make it an excellent choice for refractive surgeons, but unsurpassed control tops that feature list, said J. Charles Casebeer, MD. He spoke about the instrument, introduced in 1997 by Innovative Optics. Paradigm Medical Industries acquired that company last January and launched the K-TOME at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) here.
How to provide the best progressive lenses for your patients
July 15th 2002Progressive lenses have become the lens of choice to correct presbyopia. Although the demand and popularity of progressive lenses have increased, some doctors avoid prescribing these lenses because of past negative experiences with early lens designs and common axioms.
Head tilt test helps diagnose paralysis of eye muscles
July 15th 2002Editor's Note: The Bielschowsky head tilt test: all ophthalmologists learned it, few use it, fewer understand it, and most have forgotten it! In this month's column, we will cover the life and times of German ophthalmologist Alfred Bielschowsky (1871-1940), including his contributions to strabismus research.
Onset of glaucoma may be delayed with treatment of IOP
July 15th 2002Investigators from 22 clinical centers across the country have discovered that eye drops used to treat elevated IOP can be effective in delaying the onset of glaucoma, according to the recently released results of the Ocular Hypertension Treatment Study (OHTS).
Many still focus on controlling IOP, despite new definition
July 15th 2002New York-The official definition of glaucoma has changed over the years to downplay the role of IOP, although IOP does remain a central issue in the treatment and prevention of the condition. Such was the conclusion drawn from discussions at the Glaucoma 2002 meeting here.
Invest in advertising to become patients' first choice
July 15th 2002New York-Achieving success in an optical dispensary requires a continued, innovative marketing effort by the entire office staff, according to two experts who spoke on the subject at the American Association of Dispensing Ophthalmologists (AADO) 6th Dispensing Ophthalmology Conference held during this year's International Vision Expo East.
Anti-VEGF therapy holds promise for CNV in AMD
July 1st 2002Fort Lauderdale, FL-Anti-vascular endothelial growth factor (anti-VEGF) therapy is a promising treatment of neovascularization brought on by various ocular diseases, including age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.
Intravitreal triamcinolone for AMD appears promising, but more studies needed
July 1st 2002Fort Lauderdale, FL-Intravitreal triamcinolone appears to inhibit the growth of choroidal neovascularization (CNV) and reduce subretinal fluid in the short term, but it needs further evaluation, ac-cording to Mark Gillies, MB, BS, PhD.
AREDS supports the use of nutritional supplements for AMD
July 1st 2002Fort Lauderdale, FL-Of the nearly 60 million people in the United States over age 55, 8 million are estimated to be at high risk for advanced age-related macular degeneration (AMD), making it an important public health concern. However, nutritional supplements may be helpful to reduce this risk, according to the Age-Related Eye Disease Study (AREDS).
Obstructive sleep apnea worsens diabetic retinopathy
July 1st 2002Philadelphia-Obstructive sleep apnea appears to be a significant, previously unrecognized aggravating factor in diabetic retinopathy that promotes progression of ischemia and edema, according to Stephen Sinclair, MD, clinical professor, Hahnemann University Hospital, Philadelphia.